<DOC>
	<DOCNO>NCT00611806</DOCNO>
	<brief_summary>This study evaluate effectiveness folate B12 supplementation reduce negative symptom people schizophrenia .</brief_summary>
	<brief_title>Effectiveness Vitamin Supplementation Treating People With Residual Symptoms Schizophrenia</brief_title>
	<detailed_description>About 30 % people schizophrenia suffer treatment-resistant psychotic symptom , may include social withdrawal , apathy , depression . These negative symptom produce substantial distress affect , often disrupt social occupational function result hospitalization . Although atypical antipsychotic medication demonstrate success treat negative symptom , degree many negative symptom respond unclear . Depression poor response antidepressant medication link deficiency vitamin folate B12 . It believe vitamin supplementation folate B12 may offer safe inexpensive approach improve outcome people schizophrenia residual negative symptom exhibit poor treatment response . This study compare effectiveness folate B12 versus placebo reduce negative symptom people schizophrenia . Participation double-blind study last 19 week . Potential participant undergo initial screening , include medical psychiatric evaluation , physical exam , blood draw , urine sampling , questionnaire . Participants also ask permission use portion blood sample genetic analysis . Eligible participant randomly assign take folate B12 placebo . Participants first complete 2-week stabilization phase , follow 16-week treatment study . Medication visit , occur every 2 week treatment , include question medication side effect distribution study medication . During specified medication visit , participant complete various assessment , include questionnaire schizophrenia , test learn memory , repeat blood test , pregnancy test . The medication visit last 15 minute 4 hour , depend schedule assessment visit .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<criteria>Diagnosis schizophrenia , subtype Treated antipsychotic medication least 6 month stable dose least 6 week study entry PANSS total score least 60 , score least 3 ( moderate ) one negative symptom item one positive symptom item Simpson Angus Scale ( SAS ) Extrapyramidal Syndrome ( EPS ) total score 12 less A score 2 ( mild ) less item Calgary Depression Scale ( CDS ) Speaks English adequately enough complete cognitive test Serum B12 concentration le 300 ug/L Complete blood count result consistent megaloblastic anemia Serum creatinine concentration great 1.4 Current use folate B12 supplementation Current use follow medication : phenobarbital , phenytoin , carbamazepine , valproic acid , fosphenytoin , primidone , pyrimethamine Alcohol substance abuse within 3 month study entry ( nicotine allow ) Positive baseline urine toxic screen Unstable medical illness Unstable psychiatric illness Seizure disorder Pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>68 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Cognition</keyword>
	<keyword>Folic Acid</keyword>
	<keyword>B12</keyword>
</DOC>